We are live on ! Find out more
PYXS icon

Pyxis Oncology
PYXS

51 hedge funds and large institutions have $15.8M invested in Pyxis Oncology in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more call options, than puts

Call options by funds: $24K | Put options by funds: $2K

2.05% more ownership

Funds ownership: 17.81% → 19.85% (+2%)

3% more capital invested

Capital invested by funds: $15.4M → $15.8M (+$399K)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

6% less funds holding

Funds holding: 54 → 51 (-3)

17% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 12

18% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 11

Holders
51
Holders Change
-3
Holders Change %
-5.56%
% of All Funds
0.74%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
10
Reduced
12
Closed
11
Calls
$24K
Puts
$2K
Net Calls
+$22K
Net Calls Change
-$25K

Top Buyers

Rank Fund Capital Flow
1
Aberdeen Group
Aberdeen Group
United Kingdom
+$1.21M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$285K
3
Renaissance Technologies
Renaissance Technologies
New York
+$253K
4
Citadel Advisors
Citadel Advisors
Florida
+$183K
5
XT
XTX Topco
Cayman Islands
+$35.2K

Top Sellers

Rank Fund Capital Flow
1
ECM
ExodusPoint Capital Management
New York
-$826K
2
Bank of America
Bank of America
North Carolina
-$139K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$89K
4
Two Sigma Investments
Two Sigma Investments
New York
-$48.4K
5
Squarepoint
Squarepoint
New York
-$44.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$35.7K -$139K -81,010 -80%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$29K +$3 +2 +0%
Jane Street
28
Jane Street
New York
$27K +$25.7K +15,016 New
American Century Companies
29
American Century Companies
Missouri
$24.8K – – –
Millennium Management
30
Millennium Management
New York
$23.9K +$22.7K +13,272 New
Commonwealth Equity Services
31
Commonwealth Equity Services
Massachusetts
$23K – – –
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$21.3K -$35.5K -20,730 -64%
LPL Financial
33
LPL Financial
California
$20.6K +$19.6K +11,429 New
BFG
34
Bleakley Financial Group
New Jersey
$20.2K – – –
SS
35
Simplicity Solutions
Minnesota
$20.2K – – –
Acadian Asset Management
36
Acadian Asset Management
Massachusetts
$20K -$3.35K -1,955 -15%
KWM
37
Kingsview Wealth Management
Oregon
$19.3K – – –
Morgan Stanley
38
Morgan Stanley
New York
$11.5K +$5.48K +3,200 +100%
TRCT
39
Tower Research Capital (TRC)
New York
$10.2K +$6.26K +3,656 +184%
UBS Group
40
UBS Group
Switzerland
$5.32K – – –
Osaic Holdings
41
Osaic Holdings
Arizona
$4.74K -$8.82K -5,150 -66%
Wells Fargo
42
Wells Fargo
California
$4.56K +$39 +23 +0.9%
Group One Trading
43
Group One Trading
Illinois
$3.19K -$2.22K -1,297 -42%
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$2K -$3.97K -2,320 -71%
JP Morgan Chase
45
JP Morgan Chase
New York
$900 – – –
NA
46
NewEdge Advisors
Louisiana
$450 -$2.64K -1,542 -86%
AF
47
Allworth Financial
California
$360 – – –
WBC
48
West Branch Capital
Massachusetts
$45 – – –
Qube Research & Technologies (QRT)
49
Qube Research & Technologies (QRT)
United Kingdom
$4 – – –
GI
50
Gradient Investments
Minnesota
$2 – – –
1
2
3

PYXS Hedge Fund Activity: Q4 2023 in Review

51 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Pyxis Oncology (PYXS) for Q4 2023, worth a combined $15.8M — up 2.6% from $15.4M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of PYXS and 9 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 10 added.

The largest buyer was Aberdeen Group, opening a new position worth an estimated $1.21M. The largest seller was ExodusPoint Capital Management, exiting entirely with an estimated $826K sold.

  • 51 institutional investors held Pyxis Oncology (PYXS) as of Q4 2023, down from 54 in Q3 2023.
  • Funds reported $15.8M of Pyxis Oncology stock for Q4 2023, up 2.6% quarter-over-quarter.
  • 9 funds opened new Pyxis Oncology positions in Q4 2023 and 11 closed out, a net change of -2 holders.
  • The largest Pyxis Oncology buyer in Q4 2023 was Aberdeen Group, an estimated $1.21M added.
  • The largest Pyxis Oncology seller in Q4 2023 was ExodusPoint Capital Management, an estimated $826K sold.

Based on aggregated 13F filings for Q4 2023.